Loading, please wait ...


News Analytics

Switzerland Biotech Companies.
Currently fundraising for its Series B, Stalicla raised €22.8M in Seed and Series A in 2020 to launch the clinical development of its lead candidate and advance the identification of its second patient subgroup.
Google

Subject Matter

  • Science and technology 69.70%
  • Healthcare 30.30%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions